1. Home
  2. AMPH vs RNP Comparison

AMPH vs RNP Comparison

Compare AMPH & RNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$18.98

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Logo Cohen & Steers REIT and Preferred and Income Fund Inc.

RNP

Cohen & Steers REIT and Preferred and Income Fund Inc.

HOLD

Current Price

$21.26

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPH
RNP
Founded
1996
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
971.8M
1.0B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
AMPH
RNP
Price
$18.98
$21.26
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$28.38
N/A
AVG Volume (30 Days)
441.1K
82.2K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
7.94%
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$719,887,000.00
N/A
Revenue This Year
$6.90
N/A
Revenue Next Year
$4.64
N/A
P/E Ratio
$136.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.03
$19.27
52 Week High
$31.26
$22.99

Technical Indicators

Market Signals
Indicator
AMPH
RNP
Relative Strength Index (RSI) 35.99 61.22
Support Level $18.92 $21.20
Resistance Level $20.08 $21.33
Average True Range (ATR) 0.75 0.26
MACD -0.24 0.05
Stochastic Oscillator 12.20 80.90

Price Performance

Historical Comparison
AMPH
RNP

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

About RNP Cohen & Steers REIT and Preferred and Income Fund Inc.

Cohen & Steers REIT and Preferred Income Fund Inc is a diversified, closed-ended investment management fund. Its investment objective is to provide high current income with capital appreciation as its secondary objective. The Fund invests at least its total assets in common stocks issued by real estate investment trusts (REITs) and preferred securities under normal circumstances. The Fund seeks to achieve its objectives through a portfolio of income producing common stock issued by REITs and preferred and other debt securities.

Share on Social Networks: